Teledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19
Journal of Drugs in Dermatology · 2024
DOI: 10.36849/jdd.7819 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Justin W Marson und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatology, COVID-19, Telemedicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Marson, J. W., Chen, R. M., Ahmad, M., Litchman, G. H., Perkins, S., & Rigel, D. S. (2024). Teledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7819
Vancouver
Marson JW, Chen RM, Ahmad M, Litchman GH, Perkins S, Rigel DS. Teledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.7819
BibTeX
@article{Marson2024,
author = {Marson, Justin W and Chen, Rebecca M and Ahmad, Maham and Litchman, Graham H and Perkins, Sara and Rigel, Darrell S},
title = {Teledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19},
journal = {Journal of Drugs in Dermatology},
year = {2024},
doi = {10.36849/jdd.7819}
}
EUVIMED